Treatment of fistulas in Crohn's disease with infliximab.
Löfberg
R
R
Department of Gastroenterology, Karolinska Institute Huddinge University Hospital, Stockholm, Sweden.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications*; D004311:Double-Blind Method; D004347:Drug Interactions; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D007412:Intestinal Fistula / Q000209:etiology / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab